Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SIOX

Sio Gene Therapies (SIOX) Stock Price, News & Analysis

Sio Gene Therapies logo

About Sio Gene Therapies Stock (NASDAQ:SIOX)

Key Stats

Today's Range
$0.45
$0.48
50-Day Range
$0.38
$0.48
52-Week Range
$0.25
$0.50
Volume
40,403 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SIOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sio Gene Therapies and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SIOX Stock News Headlines

Sio Gene Therapies Stock Price History
Make this AI Trade Before EOM
President Trump is set to sign a game-changing new law… That I believe will trigger a boom in a handful of artificial intelligence coins… Giving you a chance to turn a small stake into a six-figure payout.tc pixel
Sio Gene Therapies Inc SIOX
Two Promising Gene Therapy Stocks Tackling Eye Disease
Sio Gene Therapies (NASDAQ: AXGT)
See More Headlines

SIOX Stock Analysis - Frequently Asked Questions

Sio Gene Therapies Inc. (NASDAQ:SIOX) issued its quarterly earnings data on Friday, November, 12th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by $0.12.

Shares of Sio Gene Therapies reverse split before market open on Wednesday, May 8th 2019.The 1-8 reverse split was announced on Tuesday, May 7th 2019. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 7th 2019. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sio Gene Therapies investors own include Digital Turbine (APPS), CrowdStrike (CRWD), ChargePoint (CHPT), Vuzix (VUZI) and Okta (OKTA).

Company Calendar

Last Earnings
11/12/2021
Today
9/20/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SIOX
CIK
1636050
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
No Data
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:SIOX) was last updated on 9/21/2025 by MarketBeat.com Staff
From Our Partners